Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates

This publication has 100 references indexed in Scilit:

• Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer
  Cancer Immunology, Immunotherapy, 1990
• Monocytes and impaired leukocyte migration inhibitory factor production in head and neck squamous carcinoma
  Head & Neck Surgery, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Prognostic role of antibody reactivity to melanoma.
  Journal of Clinical Investigation, 1986
• Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
  Journal of Clinical Investigation, 1983
• Spontaneous rosette formation and rosette inhibition assays in patients with squamous cell carcinoma of the head and neck
  Cancer, 1977
• ADJUVANT IMMUNO- AND/OR CHEMOTHERAPY WITH NEURAMINIDASE-TREATED AUTOGENOUS TUMOR VACCINE AND BACILLUS CALMETTEGUÉRIN FOR HEAD AND NECK CANCERS*
  Annals of the New York Academy of Sciences, 1976
• The association of the IgA levels of serum and whole saliva with the progression of oral cancer
  Cancer, 1975
• Immunocompetence in Advanced Cancer Patients prior to Chemotherapy
  Oncology, 1974